Search Results 971-980 of 17573 for treatment resistant depression

  1. Oncology (Medical) - Clinical trials

    ... treatment (refractory). Onvansertib is a ... Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer.

  2. Naltrexone (intramuscular route) - Side effects & uses - Mayo Clinic

    Naltrexone injection is used to help patients with opioid use disorder who have stopped taking opioids to stay drug-free and maintain their recovery. It is also ...

  3. A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants - Mayo Clinic

    A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R ...

  4. A Study of Transcutaneous and Epidural Spinal Stimulation for Enabling Motor Function in Humans with Motor Complete Paraplegia - Mayo Clinic

    History of chronic and/or treatment resistant urinary tract infection. ... Untreated clinical diagnosis of depression. ... Undergoing, or planning to undergo, ...

  5. GB5121 in Adult Subjects With Relapsed/Refractory CNS Lymphoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. A Study of Interpersonal and Social Rhythm Therapy for Outpatients with Bipolar Disorder - Mayo Clinic

    Confirmed diagnosis of Bipolar disorder in a depressed phase; Referred for Interpersonal and Social Rhythm Therapy. Exclusion Criteria. Active psychosis, mania ...

  7. Clinical trials - Oncology (Medical)

    PARP inhibitors are a type of targeted therapy. Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer. A Study of ...

  8. A Study of Using Lorvotuzumab Mertansine in Treating Younger Patients with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma - Mayo Clinic

    A Study of Using Lorvotuzumab Mertansine in Treating Younger Patients with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary ...

  9. Clinical trials - Oncology (Medical)

    ... therapy of TILT-123 and pembrolizumab in patients with platinum resistant or refractory ovarian cancer. BiCaZO: A Study Combining Two Immunotherapies ...

  10. Cancer Clinical Trials - Medical Professionals

    PARP inhibitors are a type of targeted therapy. Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer. A Study ...